Source link : https://newshealth.biz/health-news/paradigm-shift-in-metastatic-tnbc-to-trop2-targeted-antibody-drug-conjugates/
(MedPage Today) — BERLIN — Antibody-drug conjugates (ADCs) targeting Trop2 made a strong case as first-line standard of care for metastatic triple-negative breast cancer (TNBC) ineligible for immunotherapy, according to two randomized trials… Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118038 Author : Publish date : 2025-10-20 17:55:00 Copyright for syndicated content belongs to the linked Source.
The post Paradigm Shift in Metastatic TNBC to Trop2-Targeted Antibody-Drug Conjugates first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-20 17:55:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8